Vontobel Holding’s Immuneering IMRX Stock Holding History

Vontobel Holding’s Portfolio IMRX Stock Details IMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$65.7K	–	1344
2025 Q4	$65.7K	Sell	10,000 -11,500	-53%	-$73.8K	﹤0.01%	1392
2025 Q3	$150K	Buy	+21,500	New	+$112K	﹤0.01%	1259
2025 Q1	–	Sell	-10,000	Closed	-$22.4K	–	1121
2024 Q4	$22.4K	Hold	10,000	–	–	﹤0.01%	1090
2024 Q3	$25.1K	Buy	+10,000	New	+$14.5K	﹤0.01%	1070

Other funds holding IMRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $165M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vontobel Holding's IMRX Position: Q1 2026 in Review

Vontobel Holding sold out of Immuneering (IMRX) in Q1 2026, closing a stake of 10,000 shares — an estimated $65.7K sold.

Vontobel Holding first reported a position in IMRX in Q3 2024 and held it in 4 quarters. The position peaked at $150K in Q3 2025. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

Vontobel Holding reported no remaining Immuneering position as of Q1 2026 after selling out during the quarter.
Vontobel Holding sold 10,000 Immuneering shares in Q1 2026, an estimated $65.7K.
Vontobel Holding first reported a position in Immuneering in Q3 2024 and held it in 4 quarters.
Vontobel Holding's Immuneering position peaked at $150K in Q3 2025.
95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.